PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy

Completed

• Conditions: Heart Valve Diseases

• Registration Number: NCT01178502
• Lead Sponsor: Inje University

Brief Summary

To develop and validate the predictive warfarin dosing algorithm.

Detailed Description

This study aims to develop and validate the predictive warfarin dosing algorithm for personalized warfarin pharmacotherapy in Korean patients.

Study Timeline

• Study Start: 2008-03
• Primary Completion: 2010-04
• Study Completion: 2010-04
• Study First Submitted: 2010-08-09
• Study First Submitted QC: 2010-08-09
• Study First Posted: 2010-08-10
• Status Verified: 2013-05
• Last Update Submitted: 2013-05-30
• Last Update Posted: 2013-06-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 405

Inclusion Criteria

• the patients taking warfarin

Exclusion Criteria

• noncompliance

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To Develop and Validate the Predictive Warfarin Dosing Algorithm	1 year

Trial Locations

Locations (1)

Inje University; 🇰🇷 Busan, Korea, Republic of